Abstract
This study evaluated the effects of altering dose of PG600 on estrus and ovulation responses in prepubertal gilts and weaned sows. Experiment 1 tested the effects of one (1.0×, 400 IU eCG + 200 IU hCG, n = 74), one and a half (1.5×, n = 82), or two (2.0×, n = 71) doses of PG600 for prepubertal gilts. Estrus (58%) and ovulation (90%) were not affected ( P > 0.10) by dose. Higher doses increased ( P < 0.01) numbers of corpora lutea (17, 24, and 25), but not ( P > 0.10) the proportion of gilts with cysts (26, 36, and 46% for 1.0×, 1.5×, and 2.0×, respectively). Experiment 2 tested the effects of 0× ( n = 30), 0.5× ( n = 32), 1.0× ( n = 29), or 1.5× ( n = 30) doses of PG600 in weaned sows. Dose did not influence return to estrus (90%, P > 0.10). There was an effect of dose ( P < 0.05) on incidence of cysts (3.4, 1.8, 6.4, and 29.8%, for 0×, 0.5×, 1.0×, and 1.5× doses, respectively). The 0.5× dose increased ( P < 0.01) farrowing rate (83.2%) compared to 0× (72.1%) and 1.5× (58.6%), but was not different from 1.0× (76.4%). Total pigs born (10.5 ± 0.8) did not differ ( P > 0.10) among treatments. These data suggest that increasing dose of PG600 to 1.5× for gilts increases the number of corpora lutea but does not alter the proportion expressing estrus or ovulating. Reducing dose of PG600 for weaned sows did not alter estrus or ovulation, but the 0.5× dose increased farrowing rate compared to no PG600.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
